Boston Scientific expects to close the acquisition of Penumbra later this year. Penumbra shareholders gave their approval to the sale in May. Penumbra makes a range of devices to remove clots from the ...

Cumulative dataset of all U.S. Food and Drug Administration (FDA) marketing authorizations for artificial-intelligence and machine-learning (AI/ML)-enabled medical devices recorded between September ...

“How do they do that?” is a reasonable response to certain things we see in nature. Pythons and snakes like them can eat prey as big as they are, sometimes even bigger, and digest their massive single ...

Edison Scientific will deploy its AI scientist, Kosmos, across Incyte’s drug discovery and development work. The partnership will embed Kosmos across Incyte’s translational and clinical data to ...

Single adequate and well-controlled trial plus confirmatory evidence became the default approval paradigm, formalizing a trend already common for first-in-class oncology and rare-disease products.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary ...

The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a ...

The Food and Drug Administration said Boston Scientific will upgrade certain pacemakers to a new software as part of a recall. Boston Scientific issued a letter to affected customers recommending all ...

May 7 (Reuters) - Boston Scientific (BSX.N), opens new tab has issued an urgent recall to correct several heart devices after the U.S. Food and Drug Administration classified the action as its ‌most ...

Claude Code connects to 17,000+ stocks and financial datasets in seconds, unlocking prompts for Apple P/E ratios, Tesla income statements, and Bitcoin price changes. Welcome to your premier source for ...

The Accolade pacemaker system. [Image from Boston Scientific] The FDA today issued a new Class I recall correction that expands the scope of affected Boston Scientific (NYSE: BSX) pacemakers and ...